Tackling statin intolerance with n-of-1 trials (TaSINI) in primary care: protocol for a feasibility randomised trial to increase statin adherence

INTRODUCTION: Statins reduce the incidence of cardiovascular disease (CVD) and cause few adverse effects. Half of patients prescribed statins discontinue treatment due to perceived intolerance. Placebo-controlled (blinded) n-of-1 trials have shown people with perceived intolerance that the statin do...

Descripción completa

Detalles Bibliográficos
Autores principales: Tudor, Kate, Brooks, Jenny, Howick, Jeremy, Fox, Robin, Aveyard, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044821/
https://www.ncbi.nlm.nih.gov/pubmed/32051312
http://dx.doi.org/10.1136/bmjopen-2019-033070

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044821/
https://www.ncbi.nlm.nih.gov/pubmed/32051312
http://dx.doi.org/10.1136/bmjopen-2019-033070

Ejemplares similares